Dr. Sabeen Yaqub, MD

Dr. Yaqub practices at Surgical Specialty Care in Albuquerque, New Mexico.

Dr. Yaqub's NPI, 1639344997, was assigned on April 28, 2008. Dr. Yaqub holds New Mexico license MD2013-0963.

Dr. Yaqub's primary practice is Surgical Specialty Care, at 4901 Lang Ave Ne, Albuquerque, NM 87109. The practice phone is (505) 842-8171.

Dr. Yaqub's primary practice is Surgical Specialty Care in Albuquerque, New Mexico. Dr. Yaqub is also affiliated with Lovelace Women's Hospital. The medical group on file is New Mexico Cancer Center (NMCC). Dmand AI also links Dr. Yaqub to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account. Dr. Yaqub's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yaqub practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Yaqub's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Yaqub is licensed in New Mexico.

CMS data shows 2,680 Medicare services from Dr. Yaqub across 15 procedure codes in 2024, for 174 Medicare patients. Medicare paid $97,722 for them. Every service was in an office.

CMS counts 174 Medicare patients who saw Dr. Yaqub in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have arthritis, and 68% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yaqub's median patient age at 62, with 79% women.

In 2024, Dr. Yaqub wrote 2,908 Medicare Part D claims for 291 patients. 74% of them were for generic drugs. CMS names the drug for 2,741 of them, across 32 drugs with 11 or more claims each, at $2,836,199 in total drug cost. In 2023, CMS named 1,965 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Yaqub for performance year 2024, reported as part of a group. Dr. Yaqub accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Yaqub, published from 2018 to 2019. Dr. Yaqub's most frequent co-authors are Monthida Fangtham, Wilmer L. Sibbitt, MD and James F. Bennett, MD.

CMS Open Payments shows 198 general payments to Dr. Yaqub from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $1,155.